Cargando…
Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
OBJECTIVE: In patients with chronic coronary or peripheral artery disease enrolled in the Cardiovascular Outcomes for People Using Anticoagulation Strategies trial, randomised antithrombotic treatments were stopped after a median follow-up of 23 months because of benefits of the combination of rivar...
Autores principales: | Dagenais, Gilles R, Dyal, Leanne, Bosch, Jacqueline J, Leong, Darryl P, Aboyans, Victor, Berkowitz, Scott D, Bhatt, Deepak L, Connolly, Stuart J, Fox, Keith A A, Muehlhofer, Eva, Probstfield, Jeffrey L, Widimsky, Petr, Winkelmann, Bernhard R, Yusuf, Salim, Eikelboom, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257559/ https://www.ncbi.nlm.nih.gov/pubmed/34021038 http://dx.doi.org/10.1136/heartjnl-2020-318758 |
Ejemplares similares
-
Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
por: Camm, Christian Fielder, et al.
Publicado: (2022) -
Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme
por: Connolly, S B, et al.
Publicado: (2017) -
Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world
por: Joseph, Philip, et al.
Publicado: (2018) -
Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population
por: Chen, Xiao-jing, et al.
Publicado: (2019) -
Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery
por: Bouri, Sonia, et al.
Publicado: (2014)